Skip to main content
Top
Published in: BMC Nephrology 1/2006

Open Access 01-12-2006 | Research article

Increased blood pressure in adult offspring of families with Balkan Endemic Nephropathy: a prospective study

Authors: Plamen S Dimitrov, Valeri A Simeonov, Svetlana D Tsolova, Angel G Bonev, Rossitza B Georgieva, Wilfried J Karmaus

Published in: BMC Nephrology | Issue 1/2006

Login to get access

Abstract

Background

Previous studies have linked smaller kidney dimensions to increased blood pressure. However, patients with Balkan Endemic Nephropathy (BEN), whose kidneys shrink during the course of the disease, do not manifest increased blood pressure. The authors evaluated the relationship between kidney cortex width, kidney length, and blood pressure in the offspring of BEN patients and controls.

Methods

102 offspring of BEN patients and 99 control offspring of non-BEN hospital patients in the Vratza District, Bulgaria, were enrolled in a prospective study and examined twice (2003/04 and 2004/05). Kidney dimensions were determined using ultrasound, blood pressure was measured, and medical information was collected. The parental disease of BEN was categorized into three groups: mother, father, or both parents. Repeated measurements were analyzed with mixed regression models.

Results

In all participants, a decrease in minimal kidney cortex width of 1 mm was related to an increase in systolic blood pressure of 1.4 mm Hg (p = 0.005). There was no association between kidney length and blood pressure. A maternal history of BEN was associated with an increase in systolic blood pressure of 6.7 mm Hg (p = 0.03); paternal BEN, +3.2 mm Hg (p = 0.35); or both parents affected, +9.9 mm Hg (p = 0.002). There was a similar relation of kidney cortex width and parental history of BEN with pulse pressure; however, no association with diastolic blood pressure was found.

Conclusion

In BEN and control offspring, a smaller kidney cortex width predisposed to higher blood pressure. Unexpectedly, a maternal history of BEN was associated with average increased systolic blood pressure in offspring.
Appendix
Available only for authorised users
Literature
1.
go back to reference Andersen MJ, Agarwal R: Etiology and management of hypertension in chronic kidney disease. Med Clin North Am. 2005, 89 (3): 525-47. 10.1016/j.mcna.2004.12.001.CrossRefPubMed Andersen MJ, Agarwal R: Etiology and management of hypertension in chronic kidney disease. Med Clin North Am. 2005, 89 (3): 525-47. 10.1016/j.mcna.2004.12.001.CrossRefPubMed
2.
go back to reference Shoji T, Nishizawa Y: Chronic kidney disease as a metabolic syndrome with malnutrition – need for strict control of risk factors. Intern Med. 2005, 44 (3): 179-87. 10.2169/internalmedicine.44.179.CrossRefPubMed Shoji T, Nishizawa Y: Chronic kidney disease as a metabolic syndrome with malnutrition – need for strict control of risk factors. Intern Med. 2005, 44 (3): 179-87. 10.2169/internalmedicine.44.179.CrossRefPubMed
3.
go back to reference Danilovic V, Djurisic M, Mokranjac M, Stojimirovic B, Zivojinovic J, Stojakovic P: Porodicna oboljenia bubrega u selu Sopic izvazvana hronicnom intoksikacijom olovom. Srpski Arh Tcelok Lek. 1957, 85 (10): 1115-1125. Danilovic V, Djurisic M, Mokranjac M, Stojimirovic B, Zivojinovic J, Stojakovic P: Porodicna oboljenia bubrega u selu Sopic izvazvana hronicnom intoksikacijom olovom. Srpski Arh Tcelok Lek. 1957, 85 (10): 1115-1125.
4.
go back to reference Danilovic V, Djurisic M, Mokranjac M, Stojimirovic B, Zivojinovic J, Stojakovic P: Chronic nephritis caused by poisoning with lead via the digestive tract (flour). Presse Med. 1957, 65 (90): 2039-2040.PubMed Danilovic V, Djurisic M, Mokranjac M, Stojimirovic B, Zivojinovic J, Stojakovic P: Chronic nephritis caused by poisoning with lead via the digestive tract (flour). Presse Med. 1957, 65 (90): 2039-2040.PubMed
5.
go back to reference Radosevic Z, Radonic M: Klinicka zapazanja o "endemskoj nefropatiji" u Hrvatskoj. Lij vj. 1959, 81: 445-456. Radosevic Z, Radonic M: Klinicka zapazanja o "endemskoj nefropatiji" u Hrvatskoj. Lij vj. 1959, 81: 445-456.
6.
go back to reference Stojimirovic B, Danilovic V, Durisic M, Bogdanovic M, Radojcic V: Saobstenje o rezultatima sistematakog pregleda stanovnika sela Simicevo (Pomoravlje). Higijena. 1961, 13 (4): 355-359. Stojimirovic B, Danilovic V, Durisic M, Bogdanovic M, Radojcic V: Saobstenje o rezultatima sistematakog pregleda stanovnika sela Simicevo (Pomoravlje). Higijena. 1961, 13 (4): 355-359.
7.
go back to reference Bruckner I, Nicifor E: Endemic nephropathy in Romania. Endemic (Balkan) Nephropathy. Edited by: Stefanovic V. 1979, Nis, Inst Nephr Haemod, 11-14. Bruckner I, Nicifor E: Endemic nephropathy in Romania. Endemic (Balkan) Nephropathy. Edited by: Stefanovic V. 1979, Nis, Inst Nephr Haemod, 11-14.
8.
go back to reference Tanchev Y, Dorossiev D: The first clinical description of Balkan endemic nephropathy (1956) and its validity 35 years later. Mycotoxins, Endemic Nephropathy and Urinary Tract Tumours. Edited by: Castenagro M, Plestina R, Dirheimer G, Chernozemsky IN, Bartasch H. 1991, Lyon: International Agency for Research on Cancer, 21-8. Tanchev Y, Dorossiev D: The first clinical description of Balkan endemic nephropathy (1956) and its validity 35 years later. Mycotoxins, Endemic Nephropathy and Urinary Tract Tumours. Edited by: Castenagro M, Plestina R, Dirheimer G, Chernozemsky IN, Bartasch H. 1991, Lyon: International Agency for Research on Cancer, 21-8.
9.
go back to reference Polenakovic M: Balkan Nephropathy. Oxford Textbook of Clinical Nephrology. Edited by: Davison A, Cameron JS, Kerr DN, Ritz E, Winearls Ch. 1998, Oxford: Oxford University Press, 1202-1210. Polenakovic M: Balkan Nephropathy. Oxford Textbook of Clinical Nephrology. Edited by: Davison A, Cameron JS, Kerr DN, Ritz E, Winearls Ch. 1998, Oxford: Oxford University Press, 1202-1210.
10.
go back to reference Tanchev Y, Evstatiev Z, Dorossiev D, Pencheva J, Zvetkov G: Studies on the nephritides in the District of Vratza. Savremenna Medicina. 1956, 7 (9): 14-29. Tanchev Y, Evstatiev Z, Dorossiev D, Pencheva J, Zvetkov G: Studies on the nephritides in the District of Vratza. Savremenna Medicina. 1956, 7 (9): 14-29.
11.
go back to reference Fortza N, Negoescu M: Nefrita cronica azotemia endo-epidemica. Stud Cercet Med. 1961, 1: 217-221. Fortza N, Negoescu M: Nefrita cronica azotemia endo-epidemica. Stud Cercet Med. 1961, 1: 217-221.
12.
go back to reference Vukelic M, Sostaric B, Belicza M: Pathomorphology of Balkan endemic nephropathy. Food Chem Toxicol. 1992, 30 (3): 193-200. 10.1016/0278-6915(92)90033-H.CrossRefPubMed Vukelic M, Sostaric B, Belicza M: Pathomorphology of Balkan endemic nephropathy. Food Chem Toxicol. 1992, 30 (3): 193-200. 10.1016/0278-6915(92)90033-H.CrossRefPubMed
13.
go back to reference Djukanovic L, Bukvic D, Maric I: Creatininne clearance and kidney size in Balkan endemic nephropathy patients. Clinical Nephrology. 2004, 61 (6): 384-386.CrossRefPubMed Djukanovic L, Bukvic D, Maric I: Creatininne clearance and kidney size in Balkan endemic nephropathy patients. Clinical Nephrology. 2004, 61 (6): 384-386.CrossRefPubMed
14.
go back to reference Dimitrov P, Tsolova S, Georgieva R, Bozhilova D, Simeonov V, Bonev A, Karmaus W: Clinical markers in adult offspring of families with and without Balkan Endemic Nephropathy. Kidney Int. 2006, 69 (4): 723-9. 10.1038/sj.ki.5000120.CrossRefPubMed Dimitrov P, Tsolova S, Georgieva R, Bozhilova D, Simeonov V, Bonev A, Karmaus W: Clinical markers in adult offspring of families with and without Balkan Endemic Nephropathy. Kidney Int. 2006, 69 (4): 723-9. 10.1038/sj.ki.5000120.CrossRefPubMed
15.
go back to reference Marchand MC, Langley-Evans SC: Intrauterine programming of nephron number: the fetal flaw revisited. J Nephrol. 2001, 14 (5): 327-31.PubMed Marchand MC, Langley-Evans SC: Intrauterine programming of nephron number: the fetal flaw revisited. J Nephrol. 2001, 14 (5): 327-31.PubMed
16.
go back to reference Singh GR, Hoy WE: Kidney volume, blood pressure, and albuminuria: findings in an Australian aboriginal community. Am J Kidney Dis. 2004, 43 (2): 254-9. 10.1053/j.ajkd.2003.10.015.CrossRefPubMed Singh GR, Hoy WE: Kidney volume, blood pressure, and albuminuria: findings in an Australian aboriginal community. Am J Kidney Dis. 2004, 43 (2): 254-9. 10.1053/j.ajkd.2003.10.015.CrossRefPubMed
17.
go back to reference Mackenzie HS, Lawler EV, Brenner BM: Congenital oligonephropathy: The fetal flaw in essential hypertension?. Kidney Int. 1996, S30-4. Suppl 55 Mackenzie HS, Lawler EV, Brenner BM: Congenital oligonephropathy: The fetal flaw in essential hypertension?. Kidney Int. 1996, S30-4. Suppl 55
18.
go back to reference Nyengaard JR, Bendtsen TF: Glomerular number and size in relation to age, kidney weight, and body surface in normal man. Anat Rec. 1992, 232 (2): 194-201. 10.1002/ar.1092320205.CrossRefPubMed Nyengaard JR, Bendtsen TF: Glomerular number and size in relation to age, kidney weight, and body surface in normal man. Anat Rec. 1992, 232 (2): 194-201. 10.1002/ar.1092320205.CrossRefPubMed
19.
go back to reference Zumrutdal AO, Turan C, Cetin F, Adanali S: Relationship between renal size and hypertension in patients with chronic renal failure. Nephron. 2002, 90 (2): 145-7. 10.1159/000049034.CrossRefPubMed Zumrutdal AO, Turan C, Cetin F, Adanali S: Relationship between renal size and hypertension in patients with chronic renal failure. Nephron. 2002, 90 (2): 145-7. 10.1159/000049034.CrossRefPubMed
20.
go back to reference Danilovic V: Dijagnoza endemske nefropatije. Radovi 62 – XLVIII. Od med nauka Akad nauka i umj. BiH, Sarajevo. 1973, 17: 53-64. Danilovic V: Dijagnoza endemske nefropatije. Radovi 62 – XLVIII. Od med nauka Akad nauka i umj. BiH, Sarajevo. 1973, 17: 53-64.
22.
go back to reference Tsalev D, Lampugnani L, Georgieva R, Chakarova K: Electrothermal atomic absorption spectrometric determination of cadmium and lead with stabilized phosphate deposited on permanently modified platforms. Talanta. 2002, 58 (2): 331-340. 10.1016/S0039-9140(02)00250-3.CrossRefPubMed Tsalev D, Lampugnani L, Georgieva R, Chakarova K: Electrothermal atomic absorption spectrometric determination of cadmium and lead with stabilized phosphate deposited on permanently modified platforms. Talanta. 2002, 58 (2): 331-340. 10.1016/S0039-9140(02)00250-3.CrossRefPubMed
23.
go back to reference Little RC, Miliken G, Stroup W, Wolfinger R: SAS System for mixed models. 1996, Cary, NC: SAS Institute Inc Little RC, Miliken G, Stroup W, Wolfinger R: SAS System for mixed models. 1996, Cary, NC: SAS Institute Inc
24.
go back to reference SAS Institute: SAS/STAT Software. 2000, Cary, NC: SAS Institute Inc SAS Institute: SAS/STAT Software. 2000, Cary, NC: SAS Institute Inc
25.
go back to reference Vassilevski N, Tsolova G, Dimitrov P: Hypertension level among persons aged 25–64 in CINDI program areas. General Medicine. 2006. Vassilevski N, Tsolova G, Dimitrov P: Hypertension level among persons aged 25–64 in CINDI program areas. General Medicine. 2006.
26.
go back to reference Raman GV, Clark A, Campbell S, Watkins L, Osmond C: Is blood pressure related to kidney size and shape?. Nephrol Dial Transplant. 1998, 13 (3): 728-30. 10.1093/ndt/13.3.728.CrossRefPubMed Raman GV, Clark A, Campbell S, Watkins L, Osmond C: Is blood pressure related to kidney size and shape?. Nephrol Dial Transplant. 1998, 13 (3): 728-30. 10.1093/ndt/13.3.728.CrossRefPubMed
27.
go back to reference Paivansalo MJ, Merikanto J, Savolainen MJ, Lilja M, Rantala AO, Kauma H, Reunanen A, Kesaniemi YA, Suramo I: Effect of hypertension, diabetes and other cardiovascular risk factors on kidney size in middle-aged adults. Clin Nephrol. 1998, 50 (3): 161-8.PubMed Paivansalo MJ, Merikanto J, Savolainen MJ, Lilja M, Rantala AO, Kauma H, Reunanen A, Kesaniemi YA, Suramo I: Effect of hypertension, diabetes and other cardiovascular risk factors on kidney size in middle-aged adults. Clin Nephrol. 1998, 50 (3): 161-8.PubMed
28.
go back to reference Ots M, Troy JL, Rennke HG, Mackenzie HS, Brenner BM: Impact of the supplementation of kidney mass on blood pressure and progression of kidney disease. Nephrol Dial Transplant. 2004, 19 (2): 337-41. 10.1093/ndt/gfg549.CrossRefPubMed Ots M, Troy JL, Rennke HG, Mackenzie HS, Brenner BM: Impact of the supplementation of kidney mass on blood pressure and progression of kidney disease. Nephrol Dial Transplant. 2004, 19 (2): 337-41. 10.1093/ndt/gfg549.CrossRefPubMed
29.
go back to reference Quinkler M, Zehnder D, Eardley KS, Lepenies J, Howie AJ, Hughes SV, Cockwell P, Hewison M, Stewart PM: Increased expression of mineralocorticoid effector mechanisms in kidney biopsies of patients with heavy proteinuria. Circulation. 2005, 112 (10): 1435-43. 10.1161/CIRCULATIONAHA.105.539122.CrossRefPubMed Quinkler M, Zehnder D, Eardley KS, Lepenies J, Howie AJ, Hughes SV, Cockwell P, Hewison M, Stewart PM: Increased expression of mineralocorticoid effector mechanisms in kidney biopsies of patients with heavy proteinuria. Circulation. 2005, 112 (10): 1435-43. 10.1161/CIRCULATIONAHA.105.539122.CrossRefPubMed
30.
go back to reference Arsenovic A, Bukvic D, Trbojevic S, Maric I, Djukanovic L: Detection of renal dysfunctions in family members of patients with balkan endemic nephropathy. Am J Nephrol. 2005, 25 (1): 50-4. 10.1159/000084105.CrossRefPubMed Arsenovic A, Bukvic D, Trbojevic S, Maric I, Djukanovic L: Detection of renal dysfunctions in family members of patients with balkan endemic nephropathy. Am J Nephrol. 2005, 25 (1): 50-4. 10.1159/000084105.CrossRefPubMed
Metadata
Title
Increased blood pressure in adult offspring of families with Balkan Endemic Nephropathy: a prospective study
Authors
Plamen S Dimitrov
Valeri A Simeonov
Svetlana D Tsolova
Angel G Bonev
Rossitza B Georgieva
Wilfried J Karmaus
Publication date
01-12-2006
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2006
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-7-12

Other articles of this Issue 1/2006

BMC Nephrology 1/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.